Position in VREX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$1,042,624
-$1,257,857 QoQ
Shares Held
99,964
-53.9% QoQ
Ownership
0.237%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#53
of 186 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VREX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Empowered Funds, LLC holds $93,312,876 across 21 Medical Devices names. VREX ranks #16 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVCR |
NovoCure Ltd
|
1,154,431 | $17,489,629 | |
| 2 | ABT |
Abbott Laboratories
|
166,065 | $15,068,733 | |
| 3 | MDT |
Medtronic plc
|
162,087 | $12,680,060 | |
| 4 | SYK |
Stryker Corp
|
28,726 | $9,044,091 | |
| 5 | AHCO |
AdaptHealth Corp.
|
646,861 | $6,740,291 | |
| 6 | BSX |
Boston Scientific Corp
|
114,625 | $4,892,191 | |
| 7 | QDEL |
QuidelOrtho Corp
|
267,989 | $4,695,167 | |
| 8 | EW |
Edwards Lifesciences Corp
|
43,120 | $3,900,633 |
All Filings in VREX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,042,624 | 99,964 | Shares | Other | 2026-08-17 | |
| 2026-03-31 | $2,300,481 | 216,822 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $2,683,880 | 230,376 | Shares | Other | 2026-02-18 | |
| 2025-09-30 | $2,697,942 | 217,576 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $1,670,275 | 192,650 | Shares | Other | 2025-08-11 | |
| 2025-03-31 | $2,077,884 | 179,128 | Shares | Other | 2025-05-16 | |
| 2024-12-31 | $2,436,194 | 166,977 | Shares | Other | 2025-01-28 | |
| 2024-09-30 | $1,893,766 | 158,873 | Shares | Other | 2024-11-06 | |
| 2024-06-30 | $2,221,770 | 150,833 | Shares | Other | 2024-07-30 | |
| 2024-03-31 | $734,154 | 40,561 | Shares | Other | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||